Vassallo, M.; Durant, J.; Fabre, R.; Lotte, L.; Sindt, A.; Puchois, A.; De Monte, A.; Cezar, R.; Corbeau, P.; Pradier, C.
Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up. Viruses 2022, 14, 927.
https://doi.org/10.3390/v14050927
AMA Style
Vassallo M, Durant J, Fabre R, Lotte L, Sindt A, Puchois A, De Monte A, Cezar R, Corbeau P, Pradier C.
Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up. Viruses. 2022; 14(5):927.
https://doi.org/10.3390/v14050927
Chicago/Turabian Style
Vassallo, Matteo, Jacques Durant, Roxane Fabre, Laurene Lotte, Audrey Sindt, Annick Puchois, Anne De Monte, Renaud Cezar, Pierre Corbeau, and Christian Pradier.
2022. "Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up" Viruses 14, no. 5: 927.
https://doi.org/10.3390/v14050927
APA Style
Vassallo, M., Durant, J., Fabre, R., Lotte, L., Sindt, A., Puchois, A., De Monte, A., Cezar, R., Corbeau, P., & Pradier, C.
(2022). Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up. Viruses, 14(5), 927.
https://doi.org/10.3390/v14050927